

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 7.40601989 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.12016502 |
| 3 | regulation of activation of Janus kinase activity (GO:0010533) | 5.97564997 |
| 4 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.70617090 |
| 5 | positive regulation of natural killer cell differentiation (GO:0032825) | 5.52405864 |
| 6 | T-helper 1 type immune response (GO:0042088) | 5.35380078 |
| 7 | * regulation of T-helper 1 cell differentiation (GO:0045625) | 5.27975470 |
| 8 | protein neddylation (GO:0045116) | 5.21606390 |
| 9 | regulation of platelet aggregation (GO:0090330) | 5.15939722 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.96440588 |
| 11 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.93032825 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 4.82076673 |
| 13 | * positive regulation of T-helper cell differentiation (GO:0045624) | 4.80455747 |
| 14 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.72243020 |
| 15 | angiogenesis involved in wound healing (GO:0060055) | 4.67717772 |
| 16 | regulation of platelet activation (GO:0010543) | 4.64247524 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.60978478 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.60682243 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.60682243 |
| 20 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.46115035 |
| 21 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.42168032 |
| 22 | myeloid dendritic cell differentiation (GO:0043011) | 4.36449871 |
| 23 | positive regulation of antigen processing and presentation (GO:0002579) | 4.34634200 |
| 24 | platelet aggregation (GO:0070527) | 4.29519680 |
| 25 | * positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.28560484 |
| 26 | positive regulation of mast cell activation (GO:0033005) | 4.26184670 |
| 27 | * positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 4.25298320 |
| 28 | type I interferon signaling pathway (GO:0060337) | 4.24204149 |
| 29 | cellular response to type I interferon (GO:0071357) | 4.24204149 |
| 30 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 4.22323395 |
| 31 | granulocyte activation (GO:0036230) | 4.19106758 |
| 32 | eosinophil chemotaxis (GO:0048245) | 4.18365048 |
| 33 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.18121351 |
| 34 | response to type I interferon (GO:0034340) | 4.17206817 |
| 35 | natural killer cell mediated immunity (GO:0002228) | 4.15319336 |
| 36 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.15319336 |
| 37 | * positive regulation of type 2 immune response (GO:0002830) | 4.11684410 |
| 38 | myeloid dendritic cell activation (GO:0001773) | 4.10023505 |
| 39 | NIK/NF-kappaB signaling (GO:0038061) | 4.05913842 |
| 40 | * regulation of T-helper cell differentiation (GO:0045622) | 4.05445128 |
| 41 | negative regulation of cell killing (GO:0031342) | 4.04862385 |
| 42 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.04862385 |
| 43 | monocyte chemotaxis (GO:0002548) | 4.04530863 |
| 44 | neutrophil activation (GO:0042119) | 4.01700569 |
| 45 | regulation of hypersensitivity (GO:0002883) | 4.01120369 |
| 46 | * positive regulation of interleukin-12 production (GO:0032735) | 4.00767788 |
| 47 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.00752069 |
| 48 | positive regulation of humoral immune response (GO:0002922) | 4.00263159 |
| 49 | regulation of T cell tolerance induction (GO:0002664) | 3.99784136 |
| 50 | * regulation of alpha-beta T cell proliferation (GO:0046640) | 3.98779148 |
| 51 | negative regulation of viral genome replication (GO:0045071) | 3.94946871 |
| 52 | positive regulation of B cell differentiation (GO:0045579) | 3.94692800 |
| 53 | megakaryocyte development (GO:0035855) | 3.94447960 |
| 54 | cellular response to zinc ion (GO:0071294) | 3.94116872 |
| 55 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.93403182 |
| 56 | response to peptidoglycan (GO:0032494) | 3.93200034 |
| 57 | histamine secretion (GO:0001821) | 3.91106924 |
| 58 | positive regulation of interleukin-17 production (GO:0032740) | 3.90589135 |
| 59 | positive regulation of interferon-alpha production (GO:0032727) | 3.90162034 |
| 60 | negative regulation of T cell apoptotic process (GO:0070233) | 3.88929291 |
| 61 | blood coagulation, intrinsic pathway (GO:0007597) | 3.87363336 |
| 62 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.87300945 |
| 63 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.86737734 |
| 64 | dendritic cell chemotaxis (GO:0002407) | 3.86370320 |
| 65 | regulation of RIG-I signaling pathway (GO:0039535) | 3.84115112 |
| 66 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.82973175 |
| 67 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.81360636 |
| 68 | regulation of mononuclear cell migration (GO:0071675) | 3.79123747 |
| 69 | * positive regulation of interleukin-2 production (GO:0032743) | 3.74926865 |
| 70 | autophagic vacuole fusion (GO:0000046) | 3.73766562 |
| 71 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.71504882 |
| 72 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.70933779 |
| 73 | regulation of chronic inflammatory response (GO:0002676) | 3.69541940 |
| 74 | eosinophil migration (GO:0072677) | 3.69020750 |
| 75 | regulation of interferon-alpha production (GO:0032647) | 3.65379673 |
| 76 | cellular response to interferon-beta (GO:0035458) | 3.64868942 |
| 77 | natural killer cell differentiation (GO:0001779) | 3.64441062 |
| 78 | regulation of antigen processing and presentation (GO:0002577) | 3.64425276 |
| 79 | * regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.61414876 |
| 80 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.60055012 |
| 81 | response to interferon-beta (GO:0035456) | 3.59617863 |
| 82 | regulation of natural killer cell differentiation (GO:0032823) | 3.57935644 |
| 83 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.57168534 |
| 84 | response to muramyl dipeptide (GO:0032495) | 3.57082422 |
| 85 | * positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.55913121 |
| 86 | * regulation of T-helper 2 cell differentiation (GO:0045628) | 3.54408359 |
| 87 | * positive regulation of activated T cell proliferation (GO:0042104) | 3.53478045 |
| 88 | modulation by symbiont of host immune response (GO:0052553) | 3.53042948 |
| 89 | positive regulation by symbiont of host defense response (GO:0052509) | 3.53042948 |
| 90 | modulation by symbiont of host defense response (GO:0052031) | 3.53042948 |
| 91 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.53042948 |
| 92 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.53042948 |
| 93 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.53042948 |
| 94 | negative thymic T cell selection (GO:0045060) | 3.51522832 |
| 95 | leukocyte degranulation (GO:0043299) | 3.51297341 |
| 96 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.50289095 |
| 97 | positive regulation of granulocyte differentiation (GO:0030854) | 3.49289992 |
| 98 | adenosine metabolic process (GO:0046085) | 3.47871063 |
| 99 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.46698624 |
| 100 | response to interferon-alpha (GO:0035455) | 3.46289480 |
| 101 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.44507699 |
| 102 | defense response to protozoan (GO:0042832) | 3.44100703 |
| 103 | natural killer cell activation (GO:0030101) | 3.39492586 |
| 104 | dendritic cell differentiation (GO:0097028) | 3.37809623 |
| 105 | regulation of integrin activation (GO:0033623) | 3.32075950 |
| 106 | negative T cell selection (GO:0043383) | 3.30529638 |
| 107 | positive regulation of heat generation (GO:0031652) | 3.30503618 |
| 108 | endothelium development (GO:0003158) | 3.29883877 |
| 109 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.29581139 |
| 110 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.29528283 |
| 111 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.29092118 |
| 112 | adenosine receptor signaling pathway (GO:0001973) | 3.28649897 |
| 113 | B cell receptor signaling pathway (GO:0050853) | 3.28162549 |
| 114 | dendritic cell migration (GO:0036336) | 3.26720690 |
| 115 | regulation of mast cell activation (GO:0033003) | 3.25360704 |
| 116 | negative regulation of platelet activation (GO:0010544) | 3.25329491 |
| 117 | regulation of germinal center formation (GO:0002634) | 3.23777973 |
| 118 | positive regulation of hemostasis (GO:1900048) | 3.22407517 |
| 119 | positive regulation of blood coagulation (GO:0030194) | 3.22407517 |
| 120 | * regulation of immunoglobulin secretion (GO:0051023) | 3.22129048 |
| 121 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.21316434 |
| 122 | regulation of fever generation (GO:0031620) | 3.21065003 |
| 123 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.20811379 |
| 124 | purinergic receptor signaling pathway (GO:0035587) | 3.20804248 |
| 125 | mast cell activation (GO:0045576) | 3.20803001 |
| 126 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.20342347 |
| 127 | * regulation of interleukin-17 production (GO:0032660) | 3.20224191 |
| 128 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.19969892 |
| 129 | platelet degranulation (GO:0002576) | 3.17848854 |
| 130 | immunoglobulin mediated immune response (GO:0016064) | 3.16179779 |
| 131 | * regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.15386461 |
| 132 | negative regulation of norepinephrine secretion (GO:0010700) | 3.15149887 |
| 133 | positive regulation of natural killer cell activation (GO:0032816) | 3.15074898 |
| 134 | platelet activation (GO:0030168) | 3.12651030 |
| 135 | regulation of lipoprotein metabolic process (GO:0050746) | 3.12222119 |
| 136 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.11728087 |
| 137 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.11722064 |
| 138 | positive regulation of macrophage differentiation (GO:0045651) | 3.11663615 |
| 139 | organelle membrane fusion (GO:0090174) | 3.11188250 |
| 140 | natural killer cell activation involved in immune response (GO:0002323) | 3.10956068 |
| 141 | regulation of tolerance induction (GO:0002643) | 3.10807797 |
| 142 | * regulation of interleukin-12 production (GO:0032655) | 3.09033043 |
| 143 | * positive regulation of T cell proliferation (GO:0042102) | 3.07626766 |
| 144 | regulation of B cell differentiation (GO:0045577) | 3.06197666 |
| 145 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.05971739 |
| 146 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.04789191 |
| 147 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.04527659 |
| 148 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.01686701 |
| 149 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.01686701 |
| 150 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.00526202 |
| 151 | response to protozoan (GO:0001562) | 3.00054158 |
| 152 | positive regulation of response to biotic stimulus (GO:0002833) | 2.99633434 |
| 153 | positive regulation of interferon-beta production (GO:0032728) | 2.96744505 |
| 154 | histamine transport (GO:0051608) | 2.95822645 |
| 155 | regulation of natural killer cell activation (GO:0032814) | 2.95723414 |
| 156 | * regulation of T-helper 1 type immune response (GO:0002825) | 2.95232380 |
| 157 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.94760104 |
| 158 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.94234461 |
| 159 | positive regulation of coagulation (GO:0050820) | 2.90820913 |
| 160 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.90130908 |
| 161 | homotypic cell-cell adhesion (GO:0034109) | 2.89885990 |
| 162 | cytidine deamination (GO:0009972) | 2.88921370 |
| 163 | cytidine metabolic process (GO:0046087) | 2.88921370 |
| 164 | cytidine catabolic process (GO:0006216) | 2.88921370 |
| 165 | mast cell degranulation (GO:0043303) | 2.87526564 |
| 166 | mast cell activation involved in immune response (GO:0002279) | 2.87526564 |
| 167 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.86775413 |
| 168 | myeloid cell activation involved in immune response (GO:0002275) | 2.84997261 |
| 169 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.81401083 |
| 170 | low-density lipoprotein particle remodeling (GO:0034374) | 2.81172286 |
| 171 | regulation of mast cell degranulation (GO:0043304) | 2.80148384 |
| 172 | regulation of thymocyte apoptotic process (GO:0070243) | 2.79754808 |
| 173 | positive regulation of mast cell degranulation (GO:0043306) | 2.79361916 |
| 174 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.79361916 |
| 175 | tolerance induction (GO:0002507) | 2.78461551 |
| 176 | B cell mediated immunity (GO:0019724) | 2.77221511 |
| 177 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.77115659 |
| 178 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.76140542 |
| 179 | platelet formation (GO:0030220) | 2.75555124 |
| 180 | regulation of endothelial cell differentiation (GO:0045601) | 2.74295499 |
| 181 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.70582995 |
| 182 | positive regulation of immune response to tumor cell (GO:0002839) | 2.69918208 |
| 183 | regulation of immune response to tumor cell (GO:0002837) | 2.69918208 |
| 184 | regulation of response to tumor cell (GO:0002834) | 2.69918208 |
| 185 | positive regulation of response to tumor cell (GO:0002836) | 2.69918208 |
| 186 | definitive hemopoiesis (GO:0060216) | 2.62820007 |
| 187 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.61674459 |
| 188 | phagocytosis, engulfment (GO:0006911) | 2.61674249 |
| 189 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.61151216 |
| 190 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.60814564 |
| 191 | regulation of blood coagulation (GO:0030193) | 2.57706888 |
| 192 | regulation of hemostasis (GO:1900046) | 2.57706888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.24516119 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.44953081 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.72002781 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.57045288 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.27878982 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.85651796 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.81963669 |
| 8 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.66284970 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.57175958 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.39342482 |
| 11 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.34095895 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.20073405 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.19434118 |
| 14 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.14091547 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.11638158 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.00784079 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.78406869 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.75655605 |
| 19 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.48531241 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.17754416 |
| 21 | GATA1_19941826_ChIP-Seq_K562_Human | 2.05839526 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.97655367 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94802110 |
| 24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.94417339 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.93705874 |
| 26 | GATA2_19941826_ChIP-Seq_K562_Human | 1.90892714 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.85229557 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.83172707 |
| 29 | * MYB_26560356_Chip-Seq_TH2_Human | 1.81490545 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80808985 |
| 31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.79352574 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.72159481 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.71846326 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67331764 |
| 35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.59621602 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.58492015 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57425980 |
| 38 | * MYB_26560356_Chip-Seq_TH1_Human | 1.54357344 |
| 39 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53796932 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51887858 |
| 41 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47561339 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.46756274 |
| 43 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45683647 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.44841333 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44386676 |
| 46 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.42804230 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37106109 |
| 48 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.37010296 |
| 49 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.34962937 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.32388873 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31259048 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31057076 |
| 53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28979588 |
| 54 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28274644 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28079789 |
| 56 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27574728 |
| 57 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.26114084 |
| 58 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23562366 |
| 59 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.18324802 |
| 60 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17857200 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17390942 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16296241 |
| 63 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.15200751 |
| 64 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14368318 |
| 65 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.13882780 |
| 66 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.11723314 |
| 67 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10491316 |
| 68 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.08454086 |
| 69 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.03545410 |
| 70 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03295880 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03222912 |
| 72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02231895 |
| 73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00643785 |
| 74 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.99576678 |
| 75 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99389371 |
| 76 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.97331937 |
| 77 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.96989652 |
| 78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96700768 |
| 79 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.96592635 |
| 80 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96430106 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95896409 |
| 82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95386202 |
| 83 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94504326 |
| 84 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92753934 |
| 85 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.92645378 |
| 86 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.90894343 |
| 87 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.90259326 |
| 88 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89453134 |
| 89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88373597 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87750829 |
| 91 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86636335 |
| 92 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86607260 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.86034373 |
| 94 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.85933389 |
| 95 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85646338 |
| 96 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.84433395 |
| 97 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84180652 |
| 98 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.84178221 |
| 99 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.84099444 |
| 100 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83284472 |
| 101 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83130974 |
| 102 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83045928 |
| 103 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.82984597 |
| 104 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.82491878 |
| 105 | MAF_26560356_Chip-Seq_TH2_Human | 0.81765423 |
| 106 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80958467 |
| 107 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.80899684 |
| 108 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.80879439 |
| 109 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79081457 |
| 110 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79058340 |
| 111 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77733829 |
| 112 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77733829 |
| 113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76818849 |
| 114 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76249754 |
| 115 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.75970624 |
| 116 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.75562522 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73137767 |
| 118 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.72694193 |
| 119 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72367407 |
| 120 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.72014180 |
| 121 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.70246136 |
| 122 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.70143921 |
| 123 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.68694743 |
| 124 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.68471340 |
| 125 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.68471340 |
| 126 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.66633378 |
| 127 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.65974816 |
| 128 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.65201764 |
| 129 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.60885898 |
| 130 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.58170311 |
| 131 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.56822600 |
| 132 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.56607741 |
| 133 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.55864747 |
| 134 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.54970323 |
| 135 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.54646947 |
| 136 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.54032126 |
| 137 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.53764579 |
| 138 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.51371637 |
| 139 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.51305450 |
| 140 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.51166355 |
| 141 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.51111933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 5.23015943 |
| 2 | MP0009785_altered_susceptibility_to | 4.52717026 |
| 3 | MP0000685_abnormal_immune_system | 4.30814805 |
| 4 | * MP0002148_abnormal_hypersensitivity_rea | 4.24859487 |
| 5 | MP0003436_decreased_susceptibility_to | 4.00418241 |
| 6 | MP0005671_abnormal_response_to | 4.00376170 |
| 7 | * MP0005000_abnormal_immune_tolerance | 3.48640714 |
| 8 | MP0008004_abnormal_stomach_pH | 3.42446748 |
| 9 | MP0001790_abnormal_immune_system | 3.39552424 |
| 10 | MP0005387_immune_system_phenotype | 3.39552424 |
| 11 | MP0000465_gastrointestinal_hemorrhage | 3.38815041 |
| 12 | MP0003724_increased_susceptibility_to | 3.17221427 |
| 13 | MP0005025_abnormal_response_to | 3.16817108 |
| 14 | MP0001348_abnormal_lacrimal_gland | 3.10874976 |
| 15 | MP0006082_CNS_inflammation | 2.81988171 |
| 16 | MP0002419_abnormal_innate_immunity | 2.79362510 |
| 17 | * MP0002723_abnormal_immune_serum | 2.72071967 |
| 18 | MP0001800_abnormal_humoral_immune | 2.71851717 |
| 19 | * MP0002452_abnormal_antigen_presenting | 2.68178920 |
| 20 | MP0002163_abnormal_gland_morphology | 2.50876238 |
| 21 | * MP0001819_abnormal_immune_cell | 2.42230232 |
| 22 | MP0004510_myositis | 2.38325113 |
| 23 | * MP0002420_abnormal_adaptive_immunity | 2.36049172 |
| 24 | MP0002006_tumorigenesis | 2.35270867 |
| 25 | MP0002166_altered_tumor_susceptibility | 2.26050401 |
| 26 | MP0009764_decreased_sensitivity_to | 2.17586569 |
| 27 | MP0006054_spinal_hemorrhage | 2.14949860 |
| 28 | MP0004084_abnormal_cardiac_muscle | 2.13102838 |
| 29 | MP0005084_abnormal_gallbladder_morpholo | 2.10240378 |
| 30 | MP0005310_abnormal_salivary_gland | 2.07275900 |
| 31 | MP0001853_heart_inflammation | 1.96562970 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.95989139 |
| 33 | MP0001346_abnormal_lacrimal_gland | 1.93592866 |
| 34 | MP0002405_respiratory_system_inflammati | 1.88573207 |
| 35 | MP0003303_peritoneal_inflammation | 1.87020429 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.85172737 |
| 37 | * MP0000716_abnormal_immune_system | 1.84497527 |
| 38 | MP0004947_skin_inflammation | 1.84270610 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.84009147 |
| 40 | * MP0002398_abnormal_bone_marrow | 1.78639744 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.77429358 |
| 42 | MP0000230_abnormal_systemic_arterial | 1.73449606 |
| 43 | MP0008469_abnormal_protein_level | 1.68398557 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.63843709 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.53550097 |
| 46 | MP0008775_abnormal_heart_ventricle | 1.51390899 |
| 47 | * MP0002429_abnormal_blood_cell | 1.43811913 |
| 48 | MP0005379_endocrine/exocrine_gland_phen | 1.39924243 |
| 49 | MP0002132_abnormal_respiratory_system | 1.38674598 |
| 50 | MP0008872_abnormal_physiological_respon | 1.38481451 |
| 51 | MP0003448_altered_tumor_morphology | 1.38009553 |
| 52 | MP0010368_abnormal_lymphatic_system | 1.34490696 |
| 53 | MP0003763_abnormal_thymus_physiology | 1.34304090 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.28593131 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.27174421 |
| 56 | MP0003075_altered_response_to | 1.26722483 |
| 57 | MP0002722_abnormal_immune_system | 1.26621396 |
| 58 | MP0001879_abnormal_lymphatic_vessel | 1.23525916 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.22684569 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.22684569 |
| 61 | MP0009697_abnormal_copulation | 1.21676317 |
| 62 | MP0005646_abnormal_pituitary_gland | 1.20582770 |
| 63 | MP0002009_preneoplasia | 1.19651880 |
| 64 | MP0004036_abnormal_muscle_relaxation | 1.18148291 |
| 65 | MP0003045_fibrosis | 1.12949709 |
| 66 | MP0005083_abnormal_biliary_tract | 1.07188748 |
| 67 | MP0005410_abnormal_fertilization | 1.06207143 |
| 68 | MP0005623_abnormal_meninges_morphology | 1.06030036 |
| 69 | MP0000343_altered_response_to | 1.05502629 |
| 70 | MP0003638_abnormal_response/metabolism_ | 1.04756287 |
| 71 | MP0000858_altered_metastatic_potential | 1.03448487 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.03293029 |
| 73 | MP0002877_abnormal_melanocyte_morpholog | 1.02947955 |
| 74 | MP0002277_abnormal_respiratory_mucosa | 1.01169197 |
| 75 | MP0002736_abnormal_nociception_after | 1.00958781 |
| 76 | MP0002254_reproductive_system_inflammat | 0.97324152 |
| 77 | MP0000015_abnormal_ear_pigmentation | 0.96932696 |
| 78 | MP0009763_increased_sensitivity_to | 0.95150330 |
| 79 | MP0004130_abnormal_muscle_cell | 0.92903591 |
| 80 | MP0005165_increased_susceptibility_to | 0.90854830 |
| 81 | MP0001663_abnormal_digestive_system | 0.90548181 |
| 82 | MP0002933_joint_inflammation | 0.87179995 |
| 83 | MP0005390_skeleton_phenotype | 0.86843762 |
| 84 | MP0003091_abnormal_cell_migration | 0.86614008 |
| 85 | MP0001881_abnormal_mammary_gland | 0.85197227 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 0.83998425 |
| 87 | MP0004808_abnormal_hematopoietic_stem | 0.83915421 |
| 88 | MP0004484_altered_response_of | 0.82858290 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.82295289 |
| 90 | MP0009840_abnormal_foam_cell | 0.82251531 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.81878040 |
| 92 | MP0003183_abnormal_peptide_metabolism | 0.81752049 |
| 93 | MP0003950_abnormal_plasma_membrane | 0.80842926 |
| 94 | MP0010307_abnormal_tumor_latency | 0.80609368 |
| 95 | MP0005166_decreased_susceptibility_to | 0.80220652 |
| 96 | MP0003828_pulmonary_edema | 0.78664158 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.78590193 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.78309761 |
| 99 | MP0001968_abnormal_touch/_nociception | 0.77725673 |
| 100 | MP0004883_abnormal_blood_vessel | 0.77288312 |
| 101 | MP0000604_amyloidosis | 0.75693613 |
| 102 | MP0000703_abnormal_thymus_morphology | 0.75119787 |
| 103 | MP0009278_abnormal_bone_marrow | 0.74951457 |
| 104 | MP0003186_abnormal_redox_activity | 0.74523978 |
| 105 | MP0008874_decreased_physiological_sensi | 0.73595205 |
| 106 | MP0003795_abnormal_bone_structure | 0.72690339 |
| 107 | * MP0009642_abnormal_blood_homeostasis | 0.71245841 |
| 108 | MP0002128_abnormal_blood_circulation | 0.70735074 |
| 109 | MP0003172_abnormal_lysosome_physiology | 0.70359264 |
| 110 | MP0003866_abnormal_defecation | 0.69229719 |
| 111 | MP0002102_abnormal_ear_morphology | 0.67734860 |
| 112 | MP0004215_abnormal_myocardial_fiber | 0.67489002 |
| 113 | MP0005164_abnormal_response_to | 0.64913203 |
| 114 | MP0003279_aneurysm | 0.63056519 |
| 115 | MP0005174_abnormal_tail_pigmentation | 0.61900340 |
| 116 | MP0001851_eye_inflammation | 0.61900237 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.61485878 |
| 118 | MP0003690_abnormal_glial_cell | 0.60652324 |
| 119 | MP0005023_abnormal_wound_healing | 0.59959407 |
| 120 | MP0000627_abnormal_mammary_gland | 0.59553461 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.58716667 |
| 122 | MP0004134_abnormal_chest_morphology | 0.58052188 |
| 123 | MP0003566_abnormal_cell_adhesion | 0.57528966 |
| 124 | * MP0000249_abnormal_blood_vessel | 0.57349869 |
| 125 | MP0009780_abnormal_chondrocyte_physiolo | 0.56340286 |
| 126 | MP0001873_stomach_inflammation | 0.55391100 |
| 127 | MP0002396_abnormal_hematopoietic_system | 0.55087048 |
| 128 | MP0000490_abnormal_crypts_of | 0.55049141 |
| 129 | MP0005076_abnormal_cell_differentiation | 0.54479167 |
| 130 | MP0003943_abnormal_hepatobiliary_system | 0.52337188 |
| 131 | MP0000569_abnormal_digit_pigmentation | 0.49532759 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.45773699 |
| 133 | MP0005167_abnormal_blood-brain_barrier | 0.45459812 |
| 134 | MP0002876_abnormal_thyroid_physiology | 0.44385036 |
| 135 | MP0003300_gastrointestinal_ulcer | 0.44378090 |
| 136 | MP0001915_intracranial_hemorrhage | 0.43396459 |
| 137 | MP0000371_diluted_coat_color | 0.42636615 |
| 138 | MP0002019_abnormal_tumor_incidence | 0.42231502 |
| 139 | MP0003252_abnormal_bile_duct | 0.41937094 |
| 140 | MP0000920_abnormal_myelination | 0.40191582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 9.25547461 |
| 2 | Menorrhagia (HP:0000132) | 8.27364199 |
| 3 | Increased mean platelet volume (HP:0011877) | 8.11927612 |
| 4 | Abnormal platelet volume (HP:0011876) | 7.78178960 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.78636233 |
| 6 | Orchitis (HP:0100796) | 5.76041950 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.74621239 |
| 8 | Optic neuritis (HP:0100653) | 5.74621239 |
| 9 | Eczematoid dermatitis (HP:0000976) | 5.68697906 |
| 10 | Increased IgM level (HP:0003496) | 5.65804805 |
| 11 | Recurrent abscess formation (HP:0002722) | 5.64870519 |
| 12 | Myositis (HP:0100614) | 5.60959114 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 5.56637732 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 5.26689872 |
| 15 | Abnormal platelet function (HP:0011869) | 4.88504148 |
| 16 | Impaired platelet aggregation (HP:0003540) | 4.88504148 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.80622817 |
| 18 | Spontaneous hematomas (HP:0007420) | 4.69394593 |
| 19 | Vasculitis (HP:0002633) | 4.37109815 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 4.36522844 |
| 21 | Recurrent fungal infections (HP:0002841) | 4.23051657 |
| 22 | Chronic otitis media (HP:0000389) | 4.17433965 |
| 23 | Abnormality of macrophages (HP:0004311) | 4.14607701 |
| 24 | Recurrent viral infections (HP:0004429) | 4.00785967 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 3.96054914 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.88219000 |
| 27 | Basal ganglia calcification (HP:0002135) | 3.78659645 |
| 28 | Recurrent skin infections (HP:0001581) | 3.77985252 |
| 29 | Stomatitis (HP:0010280) | 3.69113451 |
| 30 | Hypergammaglobulinemia (HP:0010702) | 3.63594118 |
| 31 | Arterial thrombosis (HP:0004420) | 3.48545234 |
| 32 | Dyschromatopsia (HP:0007641) | 3.47216226 |
| 33 | Bruising susceptibility (HP:0000978) | 3.40980128 |
| 34 | Abnormality of T cell number (HP:0011839) | 3.37654323 |
| 35 | Keratoconjunctivitis sicca (HP:0001097) | 3.30282192 |
| 36 | Tetraparesis (HP:0002273) | 3.28595465 |
| 37 | Pulmonary infiltrates (HP:0002113) | 3.27851023 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 3.23198416 |
| 39 | Recurrent cutaneous fungal infections (HP:0011370) | 3.23187453 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.23187453 |
| 41 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.20593376 |
| 42 | Systemic lupus erythematosus (HP:0002725) | 3.17071470 |
| 43 | Joint swelling (HP:0001386) | 3.16239246 |
| 44 | Poikilocytosis (HP:0004447) | 3.11747598 |
| 45 | Nasal polyposis (HP:0100582) | 3.10196264 |
| 46 | Conjunctival telangiectasia (HP:0000524) | 3.05335647 |
| 47 | Abnormality of B cell number (HP:0010975) | 3.01571132 |
| 48 | Keratoconjunctivitis (HP:0001096) | 3.00764794 |
| 49 | B lymphocytopenia (HP:0010976) | 2.99266135 |
| 50 | Hemoptysis (HP:0002105) | 2.98329661 |
| 51 | Meningitis (HP:0001287) | 2.90740691 |
| 52 | Abnormality of the common coagulation pathway (HP:0010990) | 2.90536653 |
| 53 | Cellulitis (HP:0100658) | 2.89022153 |
| 54 | Obstructive lung disease (HP:0006536) | 2.86764146 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.86764146 |
| 56 | Abnormality of the nasal mucosa (HP:0000433) | 2.86310313 |
| 57 | Acanthocytosis (HP:0001927) | 2.78744835 |
| 58 | Leukocytosis (HP:0001974) | 2.77947112 |
| 59 | Autoimmune hemolytic anemia (HP:0001890) | 2.77812292 |
| 60 | Recurrent bronchitis (HP:0002837) | 2.75504338 |
| 61 | Gingivitis (HP:0000230) | 2.73262653 |
| 62 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.71979382 |
| 63 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.70125441 |
| 64 | Increased cerebral lipofuscin (HP:0011813) | 2.68603835 |
| 65 | Gingival bleeding (HP:0000225) | 2.66333413 |
| 66 | Encephalitis (HP:0002383) | 2.65612729 |
| 67 | Vertebral compression fractures (HP:0002953) | 2.64977647 |
| 68 | T lymphocytopenia (HP:0005403) | 2.62947653 |
| 69 | Vacuolated lymphocytes (HP:0001922) | 2.62614850 |
| 70 | Thrombocytosis (HP:0001894) | 2.62147443 |
| 71 | Abnormality of T cells (HP:0002843) | 2.61616604 |
| 72 | Periodontitis (HP:0000704) | 2.59567674 |
| 73 | Porencephaly (HP:0002132) | 2.58446939 |
| 74 | Abnormality of T cell physiology (HP:0011840) | 2.55705656 |
| 75 | Joint hemorrhage (HP:0005261) | 2.55312625 |
| 76 | Abnormal pupillary function (HP:0007686) | 2.54892116 |
| 77 | Prostate neoplasm (HP:0100787) | 2.54840954 |
| 78 | Gangrene (HP:0100758) | 2.54268746 |
| 79 | Axonal loss (HP:0003447) | 2.53842624 |
| 80 | Purpura (HP:0000979) | 2.53081524 |
| 81 | Severe combined immunodeficiency (HP:0004430) | 2.52365155 |
| 82 | Eosinophilia (HP:0001880) | 2.48103711 |
| 83 | Anorexia (HP:0002039) | 2.47945381 |
| 84 | Agammaglobulinemia (HP:0004432) | 2.47036768 |
| 85 | Abnormality of the pericardium (HP:0001697) | 2.44884565 |
| 86 | Petechiae (HP:0000967) | 2.42099464 |
| 87 | Increased density of long bones (HP:0006392) | 2.42087884 |
| 88 | Urticaria (HP:0001025) | 2.39204055 |
| 89 | Chest pain (HP:0100749) | 2.35702573 |
| 90 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.35622046 |
| 91 | Hepatosplenomegaly (HP:0001433) | 2.33233523 |
| 92 | IgA deficiency (HP:0002720) | 2.31351577 |
| 93 | Fatigue (HP:0012378) | 2.26577190 |
| 94 | IgG deficiency (HP:0004315) | 2.26320147 |
| 95 | Metaphyseal dysplasia (HP:0100255) | 2.25927979 |
| 96 | Recurrent pneumonia (HP:0006532) | 2.25699243 |
| 97 | Prolonged neonatal jaundice (HP:0006579) | 2.25422322 |
| 98 | Peritonitis (HP:0002586) | 2.23963458 |
| 99 | Chronic sinusitis (HP:0011109) | 2.23918439 |
| 100 | Decreased central vision (HP:0007663) | 2.23208676 |
| 101 | Arthralgia (HP:0002829) | 2.22901440 |
| 102 | Thyroiditis (HP:0100646) | 2.20979749 |
| 103 | Amyloidosis (HP:0011034) | 2.18249242 |
| 104 | Abnormality of eosinophils (HP:0001879) | 2.17886823 |
| 105 | Abnormality of the pleura (HP:0002103) | 2.16983376 |
| 106 | Recurrent lower respiratory tract infections (HP:0002783) | 2.16511381 |
| 107 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.16017274 |
| 108 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.15371561 |
| 109 | Osteolytic defects of the hand bones (HP:0009699) | 2.15371561 |
| 110 | Osteomyelitis (HP:0002754) | 2.14257689 |
| 111 | Hydroxyprolinuria (HP:0003080) | 2.13545878 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 2.13545878 |
| 113 | Abnormality of the prostate (HP:0008775) | 2.12234596 |
| 114 | Granulocytopenia (HP:0001913) | 2.10637095 |
| 115 | Panhypogammaglobulinemia (HP:0003139) | 2.10339246 |
| 116 | Colitis (HP:0002583) | 2.10105850 |
| 117 | Pulmonary embolism (HP:0002204) | 2.09198131 |
| 118 | Cleft eyelid (HP:0000625) | 2.08567527 |
| 119 | Cerebral ischemia (HP:0002637) | 2.05643666 |
| 120 | Amaurosis fugax (HP:0100576) | 2.05573982 |
| 121 | Vertigo (HP:0002321) | 2.05020177 |
| 122 | Progressive visual loss (HP:0000529) | 2.04783170 |
| 123 | Abnormality of lateral ventricle (HP:0030047) | 2.02527439 |
| 124 | Paralysis (HP:0003470) | 2.00258347 |
| 125 | Myocardial infarction (HP:0001658) | 1.99414035 |
| 126 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.99102383 |
| 127 | Epistaxis (HP:0000421) | 1.97172734 |
| 128 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.94475996 |
| 129 | Pustule (HP:0200039) | 1.93586411 |
| 130 | Renal cortical cysts (HP:0000803) | 1.91435308 |
| 131 | Type 2 muscle fiber atrophy (HP:0003554) | 1.88466194 |
| 132 | Abnormality of the costochondral junction (HP:0000919) | 1.81480385 |
| 133 | Mucosal telangiectasiae (HP:0100579) | 1.79095247 |
| 134 | Thrombophlebitis (HP:0004418) | 1.75901862 |
| 135 | IgM deficiency (HP:0002850) | 1.73904391 |
| 136 | Mitral stenosis (HP:0001718) | 1.71936070 |
| 137 | Inflammation of the large intestine (HP:0002037) | 1.68575283 |
| 138 | Muscle fiber atrophy (HP:0100295) | 1.68376221 |
| 139 | Combined immunodeficiency (HP:0005387) | 1.67906098 |
| 140 | Aortic dissection (HP:0002647) | 1.67116342 |
| 141 | Spontaneous abortion (HP:0005268) | 1.65702980 |
| 142 | Tinnitus (HP:0000360) | 1.65540093 |
| 143 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.65322180 |
| 144 | Abnormality of iron homeostasis (HP:0011031) | 1.64367095 |
| 145 | Dysostosis multiplex (HP:0000943) | 1.63591300 |
| 146 | Abnormality of male internal genitalia (HP:0000022) | 1.61838877 |
| 147 | Hypoproteinemia (HP:0003075) | 1.61303140 |
| 148 | Facial diplegia (HP:0001349) | 1.59404808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.54639834 |
| 2 | JAK3 | 3.84078156 |
| 3 | TYK2 | 3.78301092 |
| 4 | TBK1 | 3.60668596 |
| 5 | IKBKB | 3.16127314 |
| 6 | RIPK4 | 2.99456328 |
| 7 | IKBKE | 2.93594374 |
| 8 | BLK | 2.86620692 |
| 9 | MYLK | 2.79702353 |
| 10 | MAP3K13 | 2.69618065 |
| 11 | IRAK4 | 2.65654339 |
| 12 | MAP4K1 | 2.61329346 |
| 13 | JAK1 | 2.44669963 |
| 14 | TXK | 2.43316909 |
| 15 | EIF2AK1 | 2.33931200 |
| 16 | MAP4K2 | 2.29103840 |
| 17 | PIM2 | 2.22477813 |
| 18 | CHUK | 2.01764581 |
| 19 | ERN1 | 1.98400671 |
| 20 | GRK6 | 1.94564513 |
| 21 | BMPR2 | 1.90564545 |
| 22 | SYK | 1.80190621 |
| 23 | ARAF | 1.74077314 |
| 24 | KIT | 1.71176190 |
| 25 | PTK2B | 1.68621941 |
| 26 | NME2 | 1.60313251 |
| 27 | MAPKAPK3 | 1.58322036 |
| 28 | NUAK1 | 1.52856955 |
| 29 | GRK5 | 1.52734111 |
| 30 | PBK | 1.52509059 |
| 31 | BTK | 1.50756694 |
| 32 | IRAK3 | 1.49631296 |
| 33 | ZAP70 | 1.48850080 |
| 34 | TLK1 | 1.45033779 |
| 35 | TEC | 1.42280356 |
| 36 | MST4 | 1.41282261 |
| 37 | FES | 1.39520164 |
| 38 | MST1R | 1.35404188 |
| 39 | EIF2AK2 | 1.27548102 |
| 40 | TIE1 | 1.26441664 |
| 41 | BMX | 1.23709055 |
| 42 | STK3 | 1.22880588 |
| 43 | FRK | 1.22770324 |
| 44 | ABL2 | 1.21896576 |
| 45 | BCR | 1.21162371 |
| 46 | JAK2 | 1.20179114 |
| 47 | LCK | 1.18051736 |
| 48 | HCK | 1.17251399 |
| 49 | PIM1 | 1.16743740 |
| 50 | MUSK | 1.09457662 |
| 51 | PTK6 | 1.04772383 |
| 52 | LYN | 1.04634777 |
| 53 | TAOK3 | 0.99998801 |
| 54 | TNK2 | 0.95202515 |
| 55 | MAP3K11 | 0.95146695 |
| 56 | ILK | 0.93285444 |
| 57 | CSF1R | 0.90213759 |
| 58 | CSK | 0.87934074 |
| 59 | EPHB1 | 0.82543285 |
| 60 | PLK2 | 0.82384482 |
| 61 | TESK1 | 0.80358399 |
| 62 | PDK1 | 0.77915944 |
| 63 | TRPM7 | 0.76551706 |
| 64 | PRKCD | 0.76064838 |
| 65 | YES1 | 0.75232266 |
| 66 | PRKCQ | 0.73028322 |
| 67 | ITK | 0.72692631 |
| 68 | DAPK2 | 0.72262086 |
| 69 | FGFR3 | 0.71765274 |
| 70 | NEK9 | 0.70633159 |
| 71 | FGFR4 | 0.70114293 |
| 72 | ERBB3 | 0.68559218 |
| 73 | DAPK3 | 0.68355787 |
| 74 | MAP3K12 | 0.67551251 |
| 75 | MAP2K6 | 0.66952032 |
| 76 | MOS | 0.65728216 |
| 77 | LRRK2 | 0.65246897 |
| 78 | PKN1 | 0.65152935 |
| 79 | MAP3K5 | 0.62926057 |
| 80 | ABL1 | 0.62579262 |
| 81 | TESK2 | 0.60488387 |
| 82 | MAP2K3 | 0.59919280 |
| 83 | GRK7 | 0.58870922 |
| 84 | MAPKAPK2 | 0.57366524 |
| 85 | GRK1 | 0.57276245 |
| 86 | FER | 0.57063169 |
| 87 | MAP3K9 | 0.56177777 |
| 88 | EGFR | 0.55666777 |
| 89 | FGR | 0.55406390 |
| 90 | ADRBK1 | 0.52940312 |
| 91 | IRAK1 | 0.52426405 |
| 92 | ADRBK2 | 0.51569657 |
| 93 | TNIK | 0.51551329 |
| 94 | EIF2AK3 | 0.50817175 |
| 95 | BMPR1B | 0.50553869 |
| 96 | RPS6KA4 | 0.50190828 |
| 97 | MATK | 0.49755644 |
| 98 | EPHA3 | 0.47827812 |
| 99 | IRAK2 | 0.45831392 |
| 100 | MAP3K1 | 0.45421959 |
| 101 | PRKD1 | 0.43001625 |
| 102 | AKT3 | 0.42193885 |
| 103 | STK4 | 0.42029893 |
| 104 | STK24 | 0.40579175 |
| 105 | MAP2K1 | 0.40022623 |
| 106 | SIK3 | 0.38876071 |
| 107 | PAK1 | 0.38295017 |
| 108 | RPS6KA1 | 0.38059253 |
| 109 | NLK | 0.37610744 |
| 110 | PDPK1 | 0.37517777 |
| 111 | SGK2 | 0.36373057 |
| 112 | TGFBR2 | 0.35846382 |
| 113 | DAPK1 | 0.35490975 |
| 114 | ZAK | 0.34845591 |
| 115 | RET | 0.32634023 |
| 116 | STK10 | 0.32140552 |
| 117 | PIK3CG | 0.31954155 |
| 118 | MAPK11 | 0.31570891 |
| 119 | MAP3K8 | 0.30427851 |
| 120 | TGFBR1 | 0.29265073 |
| 121 | MAPK12 | 0.29199296 |
| 122 | PRKACG | 0.28899058 |
| 123 | KSR2 | 0.28318431 |
| 124 | PRKCH | 0.26982771 |
| 125 | HIPK2 | 0.26476936 |
| 126 | KDR | 0.26187371 |
| 127 | WNK1 | 0.25581229 |
| 128 | FLT3 | 0.25397863 |
| 129 | IGF1R | 0.23675354 |
| 130 | MARK3 | 0.23166676 |
| 131 | RPS6KA5 | 0.23151921 |
| 132 | CDK12 | 0.22688514 |
| 133 | RAF1 | 0.21716332 |
| 134 | INSR | 0.21532752 |
| 135 | CDK4 | 0.20997431 |
| 136 | FYN | 0.19693833 |
| 137 | ACVR1B | 0.18992511 |
| 138 | TTN | 0.18755722 |
| 139 | CAMKK2 | 0.17258551 |
| 140 | PIK3CA | 0.17247723 |
| 141 | CDK6 | 0.16430783 |
| 142 | SIK2 | 0.16365234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 5.29689731 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.93285697 |
| 3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.65106447 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.31576445 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.16680721 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.74142389 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.73663749 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.62033194 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.52403713 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.47455795 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.44766521 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.33282754 |
| 13 | Measles_Homo sapiens_hsa05162 | 2.19744082 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 2.09825951 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.00114216 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.95128490 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.91250811 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.90961101 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.87143376 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.78786221 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77630485 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.69967444 |
| 23 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.69937497 |
| 24 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.68343700 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.60019900 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58594212 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.54407393 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53617469 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.46981885 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.45860919 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40742626 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40234953 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37350930 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37286047 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32716602 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.31637218 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.27443157 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.27274236 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.26763032 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.21696832 |
| 41 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.17418201 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.16146110 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.15007503 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.14013215 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.13357001 |
| 46 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.11217389 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09265531 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.00596785 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.97380119 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 0.94782906 |
| 51 | Phagosome_Homo sapiens_hsa04145 | 0.93992796 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.88621956 |
| 53 | Focal adhesion_Homo sapiens_hsa04510 | 0.83069775 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.81833964 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81333188 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80543696 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80106618 |
| 58 | Long-term depression_Homo sapiens_hsa04730 | 0.79584754 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75910357 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75524607 |
| 61 | Proteasome_Homo sapiens_hsa03050 | 0.75211826 |
| 62 | Alcoholism_Homo sapiens_hsa05034 | 0.75069136 |
| 63 | Prion diseases_Homo sapiens_hsa05020 | 0.74453949 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74192274 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.74094318 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.73350318 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73346238 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73292706 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72237916 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71295449 |
| 71 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66845607 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.66818807 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66002496 |
| 74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65648945 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62875948 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57125944 |
| 77 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56127335 |
| 78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55989127 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54041422 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53700695 |
| 81 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51691388 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.51263945 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50968760 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50824051 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45862861 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45621599 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.44850732 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44052051 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.43351015 |
| 90 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.42733151 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.42586956 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42552826 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42325259 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42090310 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42085341 |
| 96 | Renin secretion_Homo sapiens_hsa04924 | 0.42042494 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41742068 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41553147 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39136733 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38741062 |
| 101 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37138078 |
| 102 | Melanoma_Homo sapiens_hsa05218 | 0.36429934 |
| 103 | Circadian entrainment_Homo sapiens_hsa04713 | 0.35629174 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35218964 |
| 105 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34312165 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33170330 |
| 107 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32169922 |
| 108 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.31677768 |
| 109 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.30126803 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.28942350 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27808150 |
| 112 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.27695676 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27596394 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23887333 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22282519 |
| 116 | Other glycan degradation_Homo sapiens_hsa00511 | 0.18351570 |
| 117 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.17980640 |
| 118 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.17630951 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.14341848 |
| 120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13859287 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.11968366 |
| 122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.11310065 |
| 123 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.08685583 |
| 124 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.08288944 |
| 125 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.08131441 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.06858939 |
| 127 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.06586303 |
| 128 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.05368390 |
| 129 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.04847765 |
| 130 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.04231202 |
| 131 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.03631283 |
| 132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.02504071 |
| 133 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.01802089 |
| 134 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.01468543 |
| 135 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.00566781 |
| 136 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | -0.0264307 |
| 137 | Ras signaling pathway_Homo sapiens_hsa04014 | -0.0224193 |
| 138 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | -0.0207452 |
| 139 | Pentose phosphate pathway_Homo sapiens_hsa00030 | -0.0102635 |

